TY  - GEN
AU  - Shibata,M
AU  - Ueshima,K
AU  - Harada,M
AU  - Nakamura,M
AU  - Hiramori,K
AU  - Endo,S
AU  - Sato,N
AU  - Mukaida,H
AU  - Suzuki,T
AU  - Suzuki,T
AU  - Inada,K
TI  - Effect of magnesium sulfate pretreatment and significance of matrix metalloproteinase-1 and interleukin-6 levels in coronary reperfusion therapy for patients with acute myocardial infarction
SN  - 0003-3197
PY  - 1999///0816
KW  - Adult
KW  - Aged
KW  - Angina Pectoris
KW  - etiology
KW  - Angioplasty, Balloon, Coronary
KW  - Arrhythmias, Cardiac
KW  - Calcium
KW  - metabolism
KW  - Calcium Channel Blockers
KW  - administration & dosage
KW  - Collagenases
KW  - blood
KW  - Complement System Proteins
KW  - drug effects
KW  - Electrocardiography
KW  - Female
KW  - Fibrinolytic Agents
KW  - therapeutic use
KW  - Humans
KW  - Incidence
KW  - Injections, Intravenous
KW  - Interleukin-6
KW  - Magnesium
KW  - Magnesium Sulfate
KW  - Male
KW  - Matrix Metalloproteinase 1
KW  - Middle Aged
KW  - Muscle, Smooth, Vascular
KW  - Myocardial Infarction
KW  - drug therapy
KW  - Myocardial Reperfusion Injury
KW  - Myocardium
KW  - Placebos
KW  - Premedication
KW  - Recurrence
KW  - Thrombolytic Therapy
KW  - Tissue Plasminogen Activator
N1  - Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1177/000331979905000707
ER  -